These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 33628593)
1. Patient-derived non-small cell lung cancer xenograft mirrors complex tumor heterogeneity. Chen X; Shen C; Wei Z; Zhang R; Wang Y; Jiang L; Chen K; Qiu S; Zhang Y; Zhang T; Chen B; Xu Y; Feng Q; Huang J; Zhong Z; Li H; Che G; Xiao K Cancer Biol Med; 2021 Feb; 18(1):184-198. PubMed ID: 33628593 [TBL] [Abstract][Full Text] [Related]
2. Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance. Kita K; Fukuda K; Takahashi H; Tanimoto A; Nishiyama A; Arai S; Takeuchi S; Yamashita K; Ohtsubo K; Otani S; Yanagimura N; Suzuki C; Ikeda H; Tamura M; Matsumoto I; Yano S Cancer Sci; 2019 Oct; 110(10):3215-3224. PubMed ID: 31432603 [TBL] [Abstract][Full Text] [Related]
3. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors. Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381 [TBL] [Abstract][Full Text] [Related]
4. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer. Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835 [TBL] [Abstract][Full Text] [Related]
6. Establishment of a platform of non-small-cell lung cancer patient-derived xenografts with clinical and genomic annotation. Kang HN; Choi JW; Shim HS; Kim J; Kim DJ; Lee CY; Hong MH; Park SY; Park AY; Shin EJ; Lee SY; Pyo KH; Yun MR; Choi HM; Lee SS; Kim SY; Lee H; Paik S; Cho BC; Lee JG; Kim HR Lung Cancer; 2018 Oct; 124():168-178. PubMed ID: 30268457 [TBL] [Abstract][Full Text] [Related]
7. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy. Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722 [TBL] [Abstract][Full Text] [Related]
9. Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers. Fichtner I; Rolff J; Soong R; Hoffmann J; Hammer S; Sommer A; Becker M; Merk J Clin Cancer Res; 2008 Oct; 14(20):6456-68. PubMed ID: 18927285 [TBL] [Abstract][Full Text] [Related]
10. Setting up a wide panel of patient-derived tumor xenografts of non-small cell lung cancer by improving the preanalytical steps. Ilie M; Nunes M; Blot L; Hofman V; Long-Mira E; Butori C; Selva E; Merino-Trigo A; Vénissac N; Mouroux J; Vrignaud P; Hofman P Cancer Med; 2015 Feb; 4(2):201-11. PubMed ID: 25470237 [TBL] [Abstract][Full Text] [Related]
11. Establishment of lung cancer patient-derived xenograft models and primary cell lines for lung cancer study. Jiang Y; Zhao J; Zhang Y; Li K; Li T; Chen X; Zhao S; Zhao S; Liu K; Dong Z J Transl Med; 2018 May; 16(1):138. PubMed ID: 29788985 [TBL] [Abstract][Full Text] [Related]
12. Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung Adenocarcinoma. Stewart EL; Mascaux C; Pham NA; Sakashita S; Sykes J; Kim L; Yanagawa N; Allo G; Ishizawa K; Wang D; Zhu CQ; Li M; Ng C; Liu N; Pintilie M; Martin P; John T; Jurisica I; Leighl NB; Neel BG; Waddell TK; Shepherd FA; Liu G; Tsao MS J Clin Oncol; 2015 Aug; 33(22):2472-80. PubMed ID: 26124487 [TBL] [Abstract][Full Text] [Related]
13. Effects of siRNA Silencing of TUG1 and LCAL6 Long Non-coding RNAs on Patient-derived Xenograft of Non-small Cell Lung Cancer. Fang T; Huang H; Li X; Liao J; Yang Z; Hoffman RM; Cheng XI; Liang L; Hu W; Yun S Anticancer Res; 2018 Jan; 38(1):179-186. PubMed ID: 29277771 [TBL] [Abstract][Full Text] [Related]
14. Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models. Hynds RE; Huebner A; Pearce DR; Hill MS; Akarca AU; Moore DA; Ward S; Gowers KHC; Karasaki T; Al Bakir M; Wilson GA; Pich O; Martínez-Ruiz C; Hossain ASMM; Pearce SP; Sivakumar M; Ben Aissa A; Grönroos E; Chandrasekharan D; Kolluri KK; Towns R; Wang K; Cook DE; Bosshard-Carter L; Naceur-Lombardelli C; Rowan AJ; Veeriah S; Litchfield K; Crosbie PAJ; Dive C; Quezada SA; Janes SM; Jamal-Hanjani M; Marafioti T; ; McGranahan N; Swanton C Nat Commun; 2024 May; 15(1):4653. PubMed ID: 38821942 [TBL] [Abstract][Full Text] [Related]
15. Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer. Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R; Deng X; Sun SY; Rossi MR; Sica GL; Ramalingam SS; Khuri FR J Transl Med; 2016 May; 14(1):111. PubMed ID: 27142472 [TBL] [Abstract][Full Text] [Related]
16. Translating the therapeutic potential of AZD4547 in FGFR1-amplified non-small cell lung cancer through the use of patient-derived tumor xenograft models. Zhang J; Zhang L; Su X; Li M; Xie L; Malchers F; Fan S; Yin X; Xu Y; Liu K; Dong Z; Zhu G; Qian Z; Tang L; Schöttle J; Zhan P; Ji Q; Kilgour E; Smith PD; Brooks AN; Thomas RK; Gavine PR Clin Cancer Res; 2012 Dec; 18(24):6658-67. PubMed ID: 23082000 [TBL] [Abstract][Full Text] [Related]
17. Establishment of patient-derived non-small cell lung cancer xenograft models with genetic aberrations within EGFR, KRAS and FGFR1: useful tools for preclinical studies of targeted therapies. Zhang XC; Zhang J; Li M; Huang XS; Yang XN; Zhong WZ; Xie L; Zhang L; Zhou M; Gavine P; Su X; Zheng L; Zhu G; Zhan P; Ji Q; Wu YL J Transl Med; 2013 Jul; 11():168. PubMed ID: 23842453 [TBL] [Abstract][Full Text] [Related]
18. Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases. Baschnagel AM; Kaushik S; Durmaz A; Goldstein S; Ong IM; Abel L; Clark PA; Gurel Z; Leal T; Buehler D; Iyer G; Scott JG; Kimple RJ Sci Rep; 2021 Jan; 11(1):2520. PubMed ID: 33510214 [TBL] [Abstract][Full Text] [Related]
19. Establishment and genetically characterization of patient-derived xenograft models of cervical cancer. Zou S; Ye M; Zhang JA; Ji H; Chen Y; Zhu X BMC Med Genomics; 2022 Sep; 15(1):191. PubMed ID: 36076209 [TBL] [Abstract][Full Text] [Related]
20. [Establishment of A Patient-derived Xenotransplantation Animal Model for Small Cell Lung Cancer and Drug Resistance Model]. Zhu Y; Huang W; Wu Y; Jia L; Li Y; Chen R; Guo L; Chen Q Zhongguo Fei Ai Za Zhi; 2019 Jan; 22(1):6-14. PubMed ID: 30674387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]